Company Filing History:
Years Active: 1990
Title: Hitoshi Nakazawa: Innovator in Hepatic Disease Treatment
Introduction
Hitoshi Nakazawa is a notable inventor based in Narita, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hepatic diseases. His innovative approach has led to the development of a unique method that offers hope for patients suffering from liver-related ailments.
Latest Patents
Hitoshi Nakazawa holds a patent for a method of curing or alleviating hepatic disease. This patent, which is a significant advancement in medical treatment, involves the administration of 1,3-dithiole-2-thione or 1,3-dithiolane-2-thione to patients. The administration can be made in various forms, including tablets, granules, powders, capsules, suspensions, injections, and suppositories. The normal dosing amount can be determined from the range of 0.01 to 50 mg/kg/day for oral administration, and 0.002 to 10 mg/kg/day for injection or other forms of administration. He has 1 patent to his name.
Career Highlights
Hitoshi Nakazawa is associated with Ss Pharmaceutical Co., Ltd., where he continues to work on innovative solutions for medical challenges. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Hitoshi has collaborated with notable colleagues, including Mari Ohtsuka and Hideaki Matsuda. Their combined efforts contribute to the advancement of medical treatments and innovations.
Conclusion
Hitoshi Nakazawa's work in developing methods for treating hepatic diseases showcases his commitment to improving patient outcomes. His innovative approach and collaboration with other professionals highlight the importance of teamwork in the field of medical research.